The Patent Finder

LKT Laboratories, Inc.

Also on record
Records under this name other than patents LKT Laboratories, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to LKT Laboratories, Inc.

PatentTitleStatus Expires Confidence
US 7,314,929Organoselenium compounds for cancer chemoprevention
Lapsed on the fee record
Ended Jan 1, 2020 · From the USPTO record
Lapsed on the fee recordEnded Jan 1, 2020From the USPTO record
US 6,166,003Heterocyclic compounds for cancer chemoprevention
Term ended
Term ended Feb 17, 2019 · From the USPTO record
Term endedTerm ended Feb 17, 2019From the USPTO record
US 7,855,232Organoselenium compound for cancer chemoprevention
Lapsed on the fee record
Ended Dec 21, 2018 · From the USPTO record
Lapsed on the fee recordEnded Dec 21, 2018From the USPTO record
US 7,087,639Organoselenium compounds for cancer chemoprevention
Lapsed on the fee record
Ended Aug 8, 2018 · From the USPTO record
Lapsed on the fee recordEnded Aug 8, 2018From the USPTO record
US 6,703,524Organoselenium compounds for cancer chemoprevention
Lapsed on the fee record
Ended Mar 9, 2016 · From the USPTO record
Lapsed on the fee recordEnded Mar 9, 2016From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited